Atara Biotherapeutics, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Atara Biotherapeutics, Inc. | ATRA - NASDAQ |
$14.00-$16.00 |
$11.00 |
$9.89 | 5 million | 10/16/2014 |
Goldman Sachs & Co., Citigroup
|
Co-Manager(s): Jefferies |
Health Care |
Filing(s): Filed 2014-06-23 Terms Added 2014-07-10 Terms Added 2014-09-28
|
For IPO Boutique's "scale of 1 to 5" BUY rating on Atara Biotherapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".
Atara Biotherapeutics, Inc. Quote & Chart - Click for current quote -
ATRA
About Atara Biotherapeutics, Inc. (adapted from Atara Biotherapeutics, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology.
This description is adapted from Atara Biotherapeutics, Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as Atara Biotherapeutics, Inc. "ATRA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved